The Lack of Association Between Ubiquinol‐cytochrome C Reductase Core Protein I (UQCRC1) Variants and Parkinson's Disease in an Eastern Chinese Population
Zhihao Lin,Ran Zheng,Yang Ruan,Ting Gao,Chongyao Jin,Nai‐Jia Xue,Jia‐Xian Dong,Yaping Yan,Jun Tian,Jiali Pu,Baorong Zhang
DOI: https://doi.org/10.1111/cns.13436
2020-01-01
CNS Neuroscience & Therapeutics
Abstract:CNS Neuroscience & TherapeuticsVolume 26, Issue 9 p. 990-992 LETTER TO THE EDITOROpen Access The lack of association between ubiquinol-cytochrome c reductase core protein I (UQCRC1) variants and Parkinson's disease in an eastern Chinese population Zhi-Hao Lin, Zhi-Hao Lin orcid.org/0000-0002-2540-703X Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorRan Zheng, Ran Zheng Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYang Ruan, Yang Ruan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorTing Gao, Ting Gao Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorChong-Yao Jin, Chong-Yao Jin Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorNai-Jia Xue, Nai-Jia Xue Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Xian Dong, Jia-Xian Dong Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYa-Ping Yan, Ya-Ping Yan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJun Tian, Jun Tian Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Li Pu, Corresponding Author Jia-Li Pu jialipu@zju.edu.cn orcid.org/0000-0002-6719-4060 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this authorBao-Rong Zhang, Corresponding Author Bao-Rong Zhang brzhang@zju.edu.cn orcid.org/0000-0002-8099-7407 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this author Zhi-Hao Lin, Zhi-Hao Lin orcid.org/0000-0002-2540-703X Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorRan Zheng, Ran Zheng Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYang Ruan, Yang Ruan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorTing Gao, Ting Gao Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorChong-Yao Jin, Chong-Yao Jin Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorNai-Jia Xue, Nai-Jia Xue Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Xian Dong, Jia-Xian Dong Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorYa-Ping Yan, Ya-Ping Yan Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJun Tian, Jun Tian Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, ChinaSearch for more papers by this authorJia-Li Pu, Corresponding Author Jia-Li Pu jialipu@zju.edu.cn orcid.org/0000-0002-6719-4060 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this authorBao-Rong Zhang, Corresponding Author Bao-Rong Zhang brzhang@zju.edu.cn orcid.org/0000-0002-8099-7407 Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China Correspondence Bao-Rong Zhang and Jia-Li Pu, Department of Neurology, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China. Email: brzhang@zju.edu.cn; jialipu@zju.edu.cnSearch for more papers by this author First published: 14 July 2020 https://doi.org/10.1111/cns.13436Citations: 3AboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, affecting approximately 2%-3% of the global population aged ≥65 years.1 The loss of dopaminergic (DA) neurons in the substantia nigral pars compacta (SNc) and intracellular α-synuclein deposition are known as PD's pivotal pathological characteristics. Although its etiology remains to be fully elucidated, the hypothesis that environmental and genetic factors play essential roles in the initiation and progression of PD is acknowledged worldwide.2 Over the past two decades, substantial progress has been made in our understanding of the genetic basis of parkinsonism through the identification of 19 monogenic disease-causing genes. In addition, emerging evidence suggests that some monogenic genes can also increase the risk of sporadic PD through different mechanisms.3 Previous studies have demonstrated that mitochondrial dysfunction plays a fundamental role in the pathogenesis of PD.4 Moreover, mitochondrial homeostasis has been related to mutations of Parkin, Pink1, and DJ-1.5 Ubiquinol-cytochrome c reductase core protein I (UQCRC1) is a component of the complex III in the respiratory chain complex. Recently, Lin et al used a whole-exome sequencing and discovered a novel candidate pathogenetic missense variant (c.941A > C p.Y314S) of the UQCRC1 gene in a Taiwanese family with autosomal dominant parkinsonism.6 To further investigate the association between UQCRC1 and PD in eastern China, we performed a UQCRC1 genetic analysis in a cohort of sporadic PD patients and healthy controls. We recruited 452 Chinese Han patients with sporadic PD and 450 sex-, age-, and ethnicity-matched healthy controls from the Second Affiliated Hospital of Zhejiang University (Hangzhou, China) between October 2016 and January 2019. All study participants were diagnosed according to the Movement Disorder Society clinical diagnostic criteria for PD.7 The basic information and demographic characteristics of participants are all shown in Data S1. All participants provided written informed consent. This study was approved by the Ethics Committee of the Second Affiliated Hospital of Zhejiang University of Medicine. Blood samples were obtained from all participants. Genomic DNA was then extracted from peripheral blood leukocytes using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's protocol. The exon and intron-exon boundaries of the UQCRC1 gene were amplified by polymerase chain reaction. Detailed information on primers and annealing temperature is shown in Data S2. DNA products were directly sequenced using a Genetic Analyzer (ABI 3730XL) and analyzed with Chromas software and Mutation Surveyor software (SoftGenetics). PD cases and healthy controls were matched for age and sex using a nonparametric test (Shapiro-Wilk normality test, P < .05) and Pearson's χ2 test, respectively. We also used Pearson's χ2 test, χ2 with Yates correction test or Fisher exact test to compare the allele frequencies in PD patients and healthy controls. The Hardy-Weinberg principle was used to ascertain the normal distribution of genotype frequencies in PD patients and healthy controls. Statistical analysis was performed using SPSS20.0 software (SPSS Inc). A two-tailed P < .05 was considered as threshold for statistical significance. The pathogenicity of missense variants was predicted using in silico tools including PolyPhen2, SIFT, CADD, as recommended by the American College of Medical Genetics and Genomics.8 In this study, we enrolled 452 sporadic PD cases and 450 healthy controls. There were no significant differences in age and sex distribution between patients and controls (Data S1). We identified three synonymous variants (p.V388=, p.A108=, and p.S473=) and four nonsynonymous variants (p.D215H, p.S4A, p.P267R, and p.N308S) of the UQCRC1 gene. The p.A108 = and p.S4A variants were detected exclusively in PD patients (Table 1). Moreover, the homozygous p.V388 = variant and the p.P267R variant were identified separately in two PD patients. However, we did not detect the previously reported p.Y314S variant (Lin et al, 2019). Analysis using publicly available resources indicated all four nonsynonymous variants should not be deleterious (Table 2). Furthermore, the frequencies of the seven variants showed no statistically significant differences between PD patients and controls. Representative images of the variants are presented in Data S3. TABLE 1. Variants identified in UQCRC1 in our study Chromosomal position Accession number Variant Number of carrying variants PD vs controls cDNA Amino acid PD Controls OR (95%CI) P Chr3:48637964 rs140583334 c.1164G>T p.V388= 42 40 1.050 (0.667-1.654) 0.833 Chr3:48642187 NA c.324C>T p.A108= 1 0 NA 1.000 Chr3:48636585 rs182453765 c.1419C>T p.S473= 12 14 0.849 (0.388-1.857) 0.682 Chr3:48641060 rs17080284 c.643G>C p.D215H 29 31 0.927 (0.549-1.565) 0.776 Chr3:48647044 NA c.10T > G p.S4A 1 0 NA 1.000 Chr3:48638807 rs149245457 c.800C>G p.P267R 22 15 1.484 (0.759-2.899) 0.245 Chr3:48638451 rs187641562 c.923A>G p.N308S 2 3 0.662 (0.110-3.982) 0.996 Abbreviations: CI, confidence interval; NA, not available; OR, odds ratio; P, P-value; PD, Parkinson's disease. TABLE 2. Allele frequencies and pathogenicity prediction of identified UQCRC1 missense variants Missense variants Freq.gnom AD(East Asian) Freq.ExAC (East Asian) Freq.1000G (East Asian) SIFT score Polyphen2 score CADD p.D215H 0.0291 0.0327 0.0238 0.097 0.997 25.4 p.S4A NA NA NA 0.274 0.175 12.69 p.P267R 0.0410 0.0360 0.0526 0.051 0.052 9 p.N308S 0.0034 0.0042 0.002 0.258 0.093 15.41 Note Threshold values for deleteriousness: SIFT <0.05; polyphen2 >0.86; CADD >15. Abbreviation: NA, not available. The UQCRC1 gene encodes ubiquinol-cytochrome c reductase core protein I, which is a subunit of complex III of the respiratory chain. As one of eleven subunits of complex III, UQCRC1 is a nuclear-encoded protein localized in the inner mitochondrial membrane. Previous studies of UQCRC1 have focused mainly on its roles in various tumors, such as malignant pleural mesothelioma and pancreatic ductal adenocarcinoma, suggesting that UQCRC1 may contribute to carcinogenesis.9, 10 Notably, mitochondrial dysfunction also plays a crucial role in the pathogenesis of PD.4, 11 Therefore, it can be hypothesized that UQCRC1 variants may play a role in the development of PD. Recently, UQCRC1 was identified as a candidate pathogenic gene for PD.6 Nevertheless, we did not find an association between sporadic PD and UQCRC1 in our study. Our data do not support that UQCRC1 mutation is a common genetic factor for sporadic patients in eastern China, but our study cannot rule out its pathogenic role in PD due to the limited ethnic background and sample size. Furthermore, in consideration of the role of outer mitochondrial membrane signaling in Parkinson's disease, proteins residing in or translocating to the outer mitochondrial membrane following mitochondrial activities deserve closer attention and be important in genetic analyses for PD.12 In conclusion, our study indicates that UQCRC1 may not be involved in pathogenesis of PD in eastern China. Further genetic analysis with larger sample sizes from diverse ethnic populations and functional assays are still needed to clarify the role of UQCRC1 in the pathogenesis of PD. ACKNOWLEDGMENTS We would like to express our gratitude to all the patients and their families who participated in this study. CONFLICT OF INTEREST The authors declare no conflicts of interest. FUNDING INFORMATION This work was supported by the National Natural Science Foundation of China (No. 81520108010 and 81771216) and the Primary Research and Development Plan of Zhejiang Province (No. 2020C03020). Supporting Information Filename Description cns13436-sup-0001-DataS1.docxWord document, 14.9 KB Data S1 cns13436-sup-0002-DataS2.docxWord document, 60.6 KB Data S2 cns13436-sup-0003-DataS3.docxWord document, 590.1 KB Data S3 Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article. REFERENCES REFERENCES 1Poewe W, Seppi K, Tanner CM, et al. Parkinson disease. Nat Rev Dis Primers. 2017; 3: 17013. CrossrefPubMedWeb of Science®Google Scholar 2Pang SY, Ho PW, Liu HF, et al. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson's disease. Transl Neurodegener. 2019; 8: 23. CrossrefPubMedWeb of Science®Google Scholar 3Reed X, Bandres-Ciga S, Blauwendraat C, Cookson MR. The role of monogenic genes in idiopathic Parkinson's disease. Neurobiol Dis. 2019; 124: 230- 239. CrossrefCASPubMedWeb of Science®Google Scholar 4Grunewald A, Kumar KR, Sue CM. New insights into the complex role of mitochondria in Parkinson's disease. Prog Neurogibol. 2019; 177: 73- 93. CrossrefCASPubMedWeb of Science®Google Scholar 5Larsen SB, Hanss Z, Krüger R. The genetic architecture of mitochondrial dysfunction in Parkinson's disease. Cell Tissue Res. 2018; 373(1): 21- 37. CrossrefCASPubMedWeb of Science®Google Scholar 6Lin CH, Chen PL, Tai CH, et al. A clinical and genetic study of early-onset and familial parkinsonism in taiwan: an integrated approach combining gene dosage analysis and next-generation sequencing. Mov Disord. 2019; 34(4): 506- 515. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar 7Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015; 30(12): 1591- 1601. Wiley Online LibraryPubMedWeb of Science®Google Scholar 8Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405- 423. CrossrefPubMedWeb of Science®Google Scholar 9Torricelli F, Saxena A, Nuamah R, et al. Genomic analysis in short- and long-term patients with malignant pleura mesothelioma treated with palliative chemotherapy. Eur J Cancer. 2020; 132: 104- 111. CrossrefCASPubMedWeb of Science®Google Scholar 10Wang Q, Li M, Gan Y, et al. Mitochondrial protein UQCRC1 is oncogenic and a potential therapeutic target for pancreatic cancer. Theranostics. 2020; 10(5): 2141- 2157. CrossrefCASPubMedWeb of Science®Google Scholar 11Cowan K, Anichtchik O, Luo S. Mitochondrial integrity in neurodegeneration. CNS Neurosci Ther. 2019; 25(7): 825- 836. Wiley Online LibraryPubMedWeb of Science®Google Scholar 12Lucero M, Suarez AE, Chambers JW. Phosphoregulation on mitochondria: Integration of cell and organelle responses. CNS Neurosci Ther. 2019; 25(7): 837- 858. Wiley Online LibraryCASPubMedWeb of Science®Google Scholar Citing Literature Volume26, Issue9September 2020Pages 990-992 ReferencesRelatedInformation
What problem does this paper attempt to address?
-
Four novel rare mutations of PLA2G6 in Chinese population with Parkinson's disease.
Ya-Xing Gui,Zhong-Ping Xu,Wen-Lv,Hong-Mei Liu,Jin-Jia Zhao,Xing-Yue Hu
DOI: https://doi.org/10.1016/j.parkreldis.2012.07.016
IF: 4.402
2013-01-01
Parkinsonism & Related Disorders
Abstract:Mutations in the phospholipase A2 Group 6 (PLA2G6) gene have been identified in autosomal recessive neurodegenerative diseases classified as infantile neuroaxonal dystrophy and neurodegeneration with brain iron accumulation. Recently, PLA2G6 was also reported as the causative gene for early-onset PARK14-linked dystonia-parkinsonism.To address whether PLA2G6 mutations are also an important cause of PD, we screened sequence variants of PLA2G6 in 250 PD patients and 550 controls in a Chinese Han populations. We identified four sequence changes: a coding synonymous c.1959T>A transition of exon13 in one patient, two missense mutations c.1966C>G in exon13 and c.2077C>G in exon14 in two different patients, which caused two amino acids change Leu656Val and Leu693Val respectively. We also found a frame-shift mutation P.His597fx69 in exon 12 in one patient. These four rare variants were not represented in 550 control individuals. Furthermore, we found that WT PLA2G6 enzyme hydrolyzed phospholipids while mutant PLA2G6 with P.His597fx69 frame-shift caused loss of enzyme activity, exhibiting less than 6% of the specific activity in phospholipase assays compared to that of WT PLA2G6. Mutant PLA2G6 with Leu656Val and Leu693Val decreased their activity by 45% and 35% in phospholipase assay respectively.We identified four rare PLA2G6 mutations in 250 PD patients, enlarging the spectrum of PLA2G6 mutations in PD. Although PLA2G6 mutations account for only a small fraction of PD patients in Chinese populations, these mutations impair catalytic activity of their phospholipids-hydrolyzing function. These results indicate that PLA2G6 mutations maybe PD-causing in Chinese Han populations.
-
Genetic Analysis of the CHCHD2 Gene in a Cohort of Chinese Patients with Parkinson Disease.
Hongwei Wu,Xingjiao Lu,Fei Xie,Zhidong Cen,Xiaosheng Zheng,Wei Luo
DOI: https://doi.org/10.1016/j.neulet.2016.06.054
IF: 3.197
2016-01-01
Neuroscience Letters
Abstract:CHCHD2 has been recently reported as a causative gene for autosomal dominant Parkinson disease (ADPD) in Japanese populations. Further genetic studies of CHCHD2 in other populations are needed. Herein, we sequenced CHCHD2 gene in 162 patients (90 from ADPD pedigrees, 72 with sporadic Parkinson disease) and 90 healthy controls in Chinese population. We observed 5 exonic variants (c.-34C>A, c.-9T>G, c.5C>T, c.*125G>A, c.*154A>G) including 1 novel variant. No pathogenic mutation was found, suggesting that CHCHD2 mutations may be rare in Chinese ADPD patients.
-
Analysis of Rare Variants of Autosomal‐dominant Genes in a Chinese Population with Sporadic Parkinson’s Disease
Ran Zheng,Chong-Yao Jin,Ying Chen,Yang Ruan,Ting Gao,Zhi-Hao Lin,Jia-Xian Dong,Ya-Ping Yan,Jun Tian,Jia-Li Pu,Bao-Rong Zhang
DOI: https://doi.org/10.1002/mgg3.1449
2020-01-01
Molecular Genetics & Genomic Medicine
Abstract:Abstract Background To date, several studies have suggested that genes involved in monogenic forms of Parkinson's disease (PD) contribute to unrelated sporadic cases, but there is limited evidence in the Chinese population. Methods We performed a systematic analysis of 12 autosomal‐dominant PD (AD‐PD) genes (SNCA, LRRK2, GIGYF2, VPS35, EIF4G1, DNAJC13, CHCHD2, HTRA2, NR4A2, RIC3, TMEM230, and UCHL1) using panel sequencing and database filtration in a case‐control study of a cohort of 391 Chinese sporadic PD patients and unrelated controls. We evaluated the association between candidate variants and sporadic PD using gene‐based analysis. Results Overall, 18 rare variants were discovered in 18.8% (36/191) of the index patients. In addition to previously reported pathogenic mutations (LRRK2 p.Arg1441His and p.Ala419Val), another four unknown variants were found in LRRK2, which also contribute to PD risk (p = 0.002; odds ratio (OR) = 7.83, 95% confidence intervals (CI) = 1.76–34.93). The cumulative frequency of undetermined rare variants was significantly higher in PD patients (14.1%) than in controls (3.5%) (p = 0.0002; OR=4.54, 95% CI = 1.93‐10.69). Conclusion Our results confirm the strong impact of LRRK2 on the risk of sporadic PD, and also provide considerable evidence of the existence of additional undetermined rare variants in AD‐PD genes that contribute to the genetic etiology of sporadic PD in a Chinese cohort.
-
UQCRC1 variants in Parkinson’s disease: a large cohort study in Chinese mainland population
Yu-wen Zhao,Hong-xu Pan,Chun-yu Wang,Qian Zeng,Yige Wang,Zheng-huan Fang,Juanjuan Huang,Xiaosong Li,Xiaoye Wang,Xi Zhang,Zhen-hua Liu,Qi-ying Sun,Qian Xu,Li-fang Lei,Xin-xiang Yan,Lu Shen,Hong Jiang,Jie-qiong Tan,Jin-chen Li,Bei-sha Tang,Hai-nan Zhang,Ji-feng Guo
DOI: https://doi.org/10.1093/brain/awab137
IF: 14.5
2021-03-29
Brain
Abstract:We read with great interest the article published recently in Brain by Lin and colleagues,1 which found rare ubiquinol-cytochrome c reductase core protein 1 (UQCRC1) variants in three autosomal-dominant Parkinson's disease families and supported the functional pathogenicity of UQCRC1 in parkinsonism using CRISPR/Cas9-based knock-in human dopaminergic SH-SY5Y cell lines, Drosophila and mouse models. As shown in this original article, after identifying the c.941A>C (p.Y314S) variant from an index family,1,2 another two novel variants of UQCRC1 (c.931A>C and an allele with concomitant c.70-1G>A and c.73_74insG) in two families were detected among 699 autosomal dominant-inherited Parkinson's disease families from several East...
neurosciences,clinical neurology
-
Genetic Analysis of ATP13A2, PLA2G6 and FBXO7 in a Cohort of Chinese Patients with Early-Onset Parkinson's Disease.
Ting Shen,Jiali Pu,Hsin-Yi Lai,Lingjia Xu,Xiaoli Si,Yaping Yan,Yasi Jiang,Baorong Zhang
DOI: https://doi.org/10.1038/s41598-018-32217-4
IF: 4.6
2018-01-01
Scientific Reports
Abstract:Several genes have already been certified as causative genes in patients with autosomal recessive early-onset Parkinson's syndrome with pyramidal tract signs, including ATP13A2, PLA2G6 and FBXO7. Variants in these three genes may also play roles in early-onset Parkinson's disease (EOPD). In order to investigate the contribution of genetic variants in these three genes to Chinese sporadic EOPD patients, we screened 101 Chinese sporadic EOPD patients and 83 age- and sex-matched healthy controls using direct sequencing. Interpretation of those detected variants was performed based on the guidelines developed by the American College of Medical Genetics and Genomics (ACMG). Two missense variants, p.G360E and p.T733M, with "uncertain significance" classification were identified in the ATP13A2 gene and five synonymous variants were significantly over-represented in EOPD patients. Two missense variants, p.R53C and p.T319M, were absent in both our control group and online databases, classified as "likely pathogenic" in the PLA2G6 gene. Only benign variants were identified in the FBXO7 gene. These results indicate that rare variants of PLA2G6 may contribute to PD susceptibility in Chinese population, the ATP13A2 might be associated with higher risk for sporadic EOPD, while the FBXO7 gene doesn't seem to be a risk factor to develop sporadic PD in Chinese population. Further biochemical and molecular biological studies needs to be conducted to support our main results in our future researches.
-
Case-control study of the UCH-L1 S18Y variant in sporadic Parkinson's disease in Chinese population
X. -X. Yan,L. Wang,J. -F. Guo,L. -L. Nie,B. -S. Tang
DOI: https://doi.org/10.1016/j.jocn.2010.07.142
IF: 2.116
2010-01-01
Journal of Clinical Neuroscience
Abstract:The ubiquitin carboxy-terminal hydrolase L1 gene (UCH-L1) has been implicated in the etiology of Parkinson’s disease (PD). In several previous studies, an S18Y (C54A) polymorphism in exon 3 of the UCH-L1 gene has been found to be protective against PD. We performed polymerase chain reaction–restriction fragment length polymorphism analysis for DNA samples from 408 Chinese patients with PD and 398 Chinese healthy controls. For the S18Y variant, there was no significant difference either in the individual allele or genotype frequencies between cases and control subjects. Possession of the S18Y variant did not alter the risk of developing PD (odds ratio: 0.827; 95% confidence interval=0.596–1.147). There was no statistically significant difference in terms of age or sex distribution between the patients and controls (p>0.05). Overall, considering our present results together with those of our previous studies, we now have access to data from more than 1000 patients from different regions of China, supporting the conclusion that the S18Y polymorphism may not have a protective effect against PD in the Chinese population.
-
Genetic Screening for Mutations in the Nrdp1 Gene in Parkinson Disease Patients in a Chinese Population
Xiaoyun Mo,Deyuan Liu,Wei Li,Zhengmao Hu,Yiqiao Hu,Jingzhi Li,Jifeng Guo,Beisha Tang,Zhuohua Zhang,Yi Bai,Kun Xia
DOI: https://doi.org/10.1016/j.parkreldis.2009.09.001
2010-01-01
Abstract:Strong evidence has shown that a defect in the Parkin gene is known to be a common, genetic cause of Parkinson disease (PD). The E3 ubiquitin ligase Nrdp1 is shown to interact with the N terminal of Parkin (the first 76 amino acids) and catalyze degradation of Parkin via the ubiquitin-proteasome pathway, suggesting that Nrdp1 may be involved in the development of PD via the regulation of Parkin, We believe we are the first to have screened PD patients for mutations in the Nrdp1 gene to determine the association between these variants and PD. By direct sequencing, we analysed the entire coding regions and 5' UTR of Nrdp1 in 209 Chinese PD patients and 302 unrelated healthy individuals. No variant was detected in the coding regions (exons 3-7); only 2 variants (c.-206 T > A and c.-208-8 A > G) were identified in the 5' UTR (exon 2) and intron 1. Furthermore, a study of the allelic and genotypic association between patients and controls showed no significant association between the c.-206 T > A polymorphism and PD; c.-208-8 A > G was identified in one PD patient and not in controls. Our data do not support the hypothesis of a major role for the Nrdp1 gene in PD development in the Chinese population.
-
Association of <i>ZNF184</i>, <i>IL1R2</i>, <i>LRRK2</i>, <i>ITPKB</i>, and <i>PARK16</i> with sporadic Parkinson's disease in Eastern China
Ting Gao,Ran Zheng,Yang Ruan,Yi Fang,Chongyao Jin,Jin Cao,Zhe Song,Jun Tian,Jiali Pu,Baorong Zhang
DOI: https://doi.org/10.1016/j.neulet.2020.135261
IF: 3.197
2020-01-01
Neuroscience Letters
Abstract:Background: Genetic factors may play important roles in the pathogenesis of Parkinson's disease, and more than 40 loci involved in Parkinson's disease have been identified. Due to differing allele frequencies across origins, the associations of these loci and sporadic Parkinson's disease in the Eastern Chinese population are still unclear. Objective: The aim of this study was to investigate the relationship between 20 single nucleotide polymorphisms and Parkinson's disease in the Eastern Chinese population. Methods: A total of 441 Parkinson's disease patients and 384 healthy controls were recruited. The MassARRAY System was used to detect 20 single nucleotide polymorphisms. Odds ratios (OR) were calculated to assess the relationship between polymorphisms and Parkinson's disease susceptibility. Results: We found that ITPKB rs4653767 (OR [95 % confidential interval (CI)] = 0.524 [0.309 - 0.922], p = 0.023), ZNF184 rs9468199 (OR [95 % CI] = 0.530 [0.326 - 0.862], p = 0.010), ILIR2 rs34043159 (OR [95 % CI] = 0.794 [0.651 - 0.968], p = 0.022), LRRK2 rs76904798 (OR [95 % CI] = 0.397 [0.225 - 0.700], p = 0.001), and PARK16 rs11240572 (OR [95 % CI] = 0.715 [0.531 - 0.962], p = 0.027) were significantly associated with Parkinson's disease. Conclusions: LRRK2 rs76904798, ZNF184 rs9468199, PARK16 rs11240572, ITPKB rs4653767, and IL1R2 rs34043159 may associate with Parkinson's disease in the Eastern Han Chinese population.
-
Association Between Dystonia-Related Genetic Loci and Parkinson's Disease in Eastern China
Wen-Yi Yang,Si-Si Jiang,Jia-Li Pu,Chong-Yao Jin,Ting Gao,Ran Zheng,Jun Tian,Bao-Rong Zhang
DOI: https://doi.org/10.3389/fneur.2021.711050
IF: 3.4
2022-01-01
Frontiers in Neurology
Abstract:Background Parkinson's disease (PD) and dystonia are closely related in terms of pathophysiology and clinical manifestations, but their common genetic characteristics remain unclear. Some genome-wide association studies (GWASs) and replication studies have revealed correlations between single nucleotide polymorphisms (SNPs) of the ARSG, BDNF, NALCN, OR4X2, KIAA1715, and OR4B1 genes and dystonia. This study was conducted to assess the association between these genetic loci and PD in a population from Eastern China. Methods We genotyped the SNPs (rs11655081 of ARSG; rs6265 of BDNF; rs61973742, rs1338051, rs9518384, and rs9518385 of NALCN; rs67863238 of OR4X2; rs10930717 of KIAA1715; and rs35875350 of OR4B1) in a cohort of 474 patients with PD and 439 healthy controls from East China. To determine the genotypes of these SNPs, we used an Agena MassARRAY Typer 4.0. Odds ratios (ORs) and 95% CIs were computed to evaluate the correlations between these SNPs and the risk of PD. Results There were significant differences in the genotype distribution (OR = 0.649, 95% CI = 0.478–0.880) and minor allele frequency (MAF) (OR = 0.703, 95% CI = 0.533–0.929) of SNP rs61973742 (NALCN) between patients with PD and healthy controls. A significant difference was detected in the genotype distribution of rs11655081 (ARSG) (OR = 1.486, 95% CI = 1.080–2.045). Conclusion Single nucleotide polymorphisms rs11655081 (ARSG) and rs61973742 (NALCN) may be associated with PD. The C allele of rs11655081 may increase the risk of PD, whereas the G allele of rs61973742 may be a protective factor.
-
Association study between two novel single nucleotide polymorphisms and sporadic Parkinson's disease in Chinese Han population.
Kai Li,Bei-sha Tang,Ri-li Yu,Zhan-yun Lv,Qi-ying Sun,Qian Li,Kun Xia,Xin-xiang Yan,Ji-feng Guo
DOI: https://doi.org/10.1016/j.neulet.2012.04.024
IF: 3.197
2012-01-01
Neuroscience Letters
Abstract:Two novel single nucleotide polymorphisms (SNPs) (rs6812193 and rs11868035) were recently identified to be associated with Parkinson's disease (PD) in a Web Based Genome-Wide Association Study. Herein, we conducted a case-control study to evaluate the possible associations between these two SNPs and PD in Chinese Han population. All subjects (501 sporadic PD patients and 502 normal controls) were genotyped using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis with these two SNPs. Chi-square test revealed no significant difference in either genotype frequencies or allele frequencies, even after being stratified by age. But we found that the genotype and allele frequency of rs6812193 shows difference between male patients and male controls (p=0.031, OR=0.584; p=0.037, OR=0.606) but none in the female. Our findings suggest that rs11868035 may have no association with PD in Chinese population and rs6812193 may have marginal association with PD in male Chinese population. However, due to the limited data in the present study, replication studies in larger sample and other populations are required.
-
An Association Between the PARK16 Locus and Parkinson’s Disease in a Cohort from Eastern China
Ya-Ping Yan,Xiao-Yun Mo,Jun Tian,Guo-Hua Zhao,Xin-Zhen Yin,Fan-Ying Jin,Bao-Rong Zhang
DOI: https://doi.org/10.1016/j.parkreldis.2011.07.012
2011-01-01
Abstract:Genome-wide association studies (GWAS) have identified several single-nucleotide polymorphisms (SNPs) at the PARK16 locus that can modulate the risk of Parkinson's disease (PD), including rs16856139, rs823128, rs823122, rs947211, rs823156, rs708730 and rs11240572. The strength of these associations has been investigated in people from several ethnic origins, including Europe, Chile, Japan, Taiwan and western China. The results have shown that an ethnicity-specific effect is an important consideration in such an analysis. Therefore, we genotyped the above seven SNPs using a case-control methodology to explore their association with the risk of PD in eastern China. A total of 456 study subjects comprising 226 patients with PD and 230 unrelated healthy controls were recruited. The minor allele frequencies at the rs16856139 and rs11240572 SNPs were found to be significantly higher in controls than in PD cases, which suggested that they conferred a protective effect against PD. Further analyses from more diverse ethnic origins are required to confirm the significance of rs16856139 and rs11240572.
-
Study of GCH1 and TH genes in Chinese patients with Parkinson's disease.
Ya-Ping Yan,Bo Zhang,Ting Shen,Xiao-Li Si,Zhang-Yu Guo,Jun Tian,Cong-Ying Xu,Bao-Rong Zhang
DOI: https://doi.org/10.1016/j.neurobiolaging.2018.02.004
IF: 5.133
2018-01-01
Neurobiology of Aging
Abstract:Whole-exome sequencing of Parkinson's disease (PD) patients has revealed that the frequency of GTP-cyclohydrolase I (GCH1) variants was significantly higher in patients than in controls. GCH1 rs11158026 was also found to increase the risk of PD. To investigate genetic contribution of dopa-responsive dystonia–related genes to PD, GCH1, and tyrosine hydroxylase (TH) were tested in PD patients. A total of 859 study subjects comprising 421 patients with PD and 438 controls were recruited. For GCH1 gene, one known variant (c.239G > A, p.S80N) was detected in a patient who was diagnosed with PD clinically. In TH, 3 heterozygous variants, c.1495G > A (p. V499M, rs1800033), c.334 A > G (p.V112M, rs6356), and c.813 G > A (p. K271K, rs6357), were identified. After stratification by age, the frequency of rs6356G allele was significantly lower (p = 0.041) for the late-onset PD group than controls. Our results indicate that to analyze the relationship between dopa-responsive dystonia–related genes and PD, it is important to screen GCH1 and test rs6356 of TH in a larger sample.
-
Mitochondrial UQCRC1 mutations cause autosomal dominant parkinsonism with polyneuropathy
Chin-Hsien Lin,Pei-I Tsai,Han-Yi Lin,Nobutaka Hattori,Manabu Funayama,Beomseok Jeon,Kota Sato,Koji Abe,Yohei Mukai,Yuji Takahashi,Yuanzhe Li,Kenya Nishioka,Hiroyo Yoshino,Kensuke Daida,Meng-Ling Chen,Jay Cheng,Cheng-Yen Huang,Shiou-Ru Tzeng,Yen-Sheng Wu,Hsing-Jung Lai,Hsin-Hsi Tsai,Ruoh-Fang Yen,Ni-Chung Lee,Wen-Chun Lo,Yu-Chien Hung,Chih-Chiang Chan,Yi-Ci Ke,Chi-Chao Chao,Sung-Tsang Hsieh,Matthew Farrer,Ruey-Meei Wu
DOI: https://doi.org/10.1093/brain/awaa279
IF: 14.5
2020-11-01
Brain
Abstract:Abstract Parkinson’s disease is a neurodegenerative disorder with a multifactorial aetiology. Nevertheless, the genetic predisposition in many families with multi-incidence disease remains unknown. This study aimed to identify novel genes that cause familial Parkinson’s disease. Whole exome sequencing was performed in three affected members of the index family with a late-onset autosomal-dominant parkinsonism and polyneuropathy. We identified a novel heterozygous substitution c.941A>C (p.Tyr314Ser) in the mitochondrial ubiquinol-cytochrome c reductase core protein 1 (UQCRC1) gene, which co-segregates with disease within the family. Additional analysis of 699 unrelated Parkinson’s disease probands with autosomal-dominant Parkinson’s disease and 1934 patients with sporadic Parkinson’s disease revealed another two variants in UQCRC1 in the probands with familial Parkinson’s disease, c.931A>C (p.Ile311Leu) and an allele with concomitant splicing mutation (c.70-1G>A) and a frameshift insertion (c.73_74insG, p.Ala25Glyfs*27). All substitutions were absent in 1077 controls and the Taiwan Biobank exome database from healthy participants (n = 1517 exomes). We then assayed the pathogenicity of the identified rare variants using CRISPR/Cas9-based knock-in human dopaminergic SH-SY5Y cell lines, Drosophila and mouse models. Mutant UQCRC1 expression leads to neurite degeneration and mitochondrial respiratory chain dysfunction in SH-SY5Y cells. UQCRC1 p.Tyr314Ser knock-in Drosophila and mouse models exhibit age-dependent locomotor defects, dopaminergic neuronal loss, peripheral neuropathy, impaired respiratory chain complex III activity and aberrant mitochondrial ultrastructures in nigral neurons. Furthermore, intraperitoneal injection of levodopa could significantly improve the motor dysfunction in UQCRC1 p.Tyr314Ser mutant knock-in mice. Taken together, our in vitro and in vivo studies support the functional pathogenicity of rare UQCRC1 variants in familial parkinsonism. Our findings expand an additional link of mitochondrial complex III dysfunction in Parkinson’s disease.
neurosciences,clinical neurology
-
[Association Analysis of the Parkin Gene in Patients with Sporadic Parkinson's Disease from a Han Population of Sichuan Province].
Rong Peng,Wen-jun Chen,Yan Wu,Ming Liu,Xiao-hui Lai,Jin-hong Zhang,Guang-gu Yuan,Ying-ru Gou,Tao Li,Ying-cheng Wang
DOI: https://doi.org/10.3760/j.issn:1003-9406.2007.01.010
2007-01-01
Abstract:OBJECTIVE:To determine whether there are any associations between the -258T/G polymorphism of the promoter and the IVS3 -20T/C polymorphism in parkin gene and Parkinson's disease (PD) from a Han population in Sichuan province.METHODS:Polymerase chain reaction (PCR), restriction fragment length polymorphism, denaturing high performance liquid chromatography(dHPLC) and sequence analysis were used to determine the genotype of each subject. The -258T/G polymorphism and IVS3 -20T/C polymorphism were analysed in 198 patients with sporadic PD and 187 healthy controls, matched for age and gender.RESULTS:There were significant differences in allele frequency of the -258T/G polymorphism between PD patients and controls, with the G allele more common in cases than controls (52.5% vs 43.3%; chi square is 6.17, P< 0.025, OR is 1.45, 95% CI 1.04-1.86). There were also significant differences in G allele frequency between PD patients with onset age over 50 years old and controls(chi square is 9.048, P< 0.01, OR is 1.57, 95% CI:1.08-2.06). The frequency of TG+GG genotype was significantly higher in PD patients than in controls (78.79% vs 69.51%; chi square is 3.854, P< 0.05, OR is 1.63, 95% CI:0.88-2.38). In addition, there were significant differences in age of onset between PD patients with different genotypes (P< 0.05). The average age of onset in group of GG genotype was later about 5 years compared with the group of TT or TG genotype. The frequency of CC genotype in IVS3 -20T/C polymorphism was much higher than that of TC genotype. No TT genotype was found.CONCLUSION:This study suggests that the parkin promoter -258T/G polymorphism might be a risk factor for late onset PD in Sichuan. CC genotype for IVS3 -20T/C polymorphism is common in Sichuan Han population. No TT genotype for IVS3 -20T/C polymorphism is found in Sichuan Han population.
-
Haplotype Analysis on the Relationship of the DNAJC6 Gene with Early-Onset Parkinson's Disease Risk in a Chinese Population.
Ting Shen,Shuai Zhao,Yasi Jiang,Jiali Pu,Hsin-Yi Lai,Yaping Yan,Jun Tian,Yanxin Chen,Baorong Zhang
DOI: https://doi.org/10.3233/jpd-181411
2019-01-01
Abstract:BACKGROUND:DNAJC6 gene is one of the Parkinson's disease (PD) related genes, but relationship between DNAJC6 polymorphisms and PD remains unclear.OBJECTIVE:We aims to examine the association between genetic variations in DNAJC6 gene and idiopathic early-onset PD (EOPD) in the Chinese population.METHODS:Exons and intron/exon boundaries of DNAJC6 gene was amplified and sequenced in 135 EOPD patients and 212 healthy controls. Single nucleotide polymorphisms (SNP)-based and haplotype-based association study between EOPD and DNAJC6 was conducted. SNP-SNP interactions were investigated using the generalized multifactor dimensionality reduction (GMDR) method. We further evaluated the effect of variants on gene function and expression using online in silico algorithms and databases.RESULTS:We found fourteen previously reported SNPs in the DNAJC6 gene. The frequencies of variant alleles in rs11208644, rs4582839 and rs4915691 were observed significantly higher in EOPD group compared to healthy controls, while in rs6588144 was significantly lower. Additionally, haplotype analysis indicated that the CTCACTCGGC, CTTACTCGGC and TTTGTTCGAC haplotypes were associated with higher EOPD risk in EOPD patients. SNP-SNP interaction analysis showed that rs12077111-rs4592284 SNP combination was the best model with higher EOPD risk. Based on the in silico analysis results, these SNPs were predicted to be no harm to the protein function, but might lead to possible changes in splice site and alter the expression level of DNAJC6.CONCLUSION:Our study indicated that EOPD was associated with several SNPs and haplotypes of DNAJC6 gene.
-
Single-cell RNA sequencing reveals peripheral immunological features in Parkinson's Disease
Liu-Lin Xiong,Ruo-Lan Du,Rui-Ze Niu,Lu-Lu Xue,Li Chen,Li-Ren Huangfu,Xiao-Xing Cai,Xiu-Ying He,Jin Huang,Xue-Yan Huang,Jia Liu,Chang-Yin Yu,Wen-Yuan Wang,Ting-Hua Wang
DOI: https://doi.org/10.1038/s41531-024-00790-3
2024-10-04
Abstract:Although many researchers of Parkinson's disease (PD) have shifted their focus from the central nervous system (CNS) to the peripheral blood, a significant knowledge gap remains between PD severity and the peripheral immune response. In the current study, we aimed to map the peripheral immunity atlas in peripheral blood mononuclear cells (PBMCs) from PD patients and healthy controls using single-cell RNA sequencing (scRNA-seq). Our study employed scRNA-seq analysis to map the peripheral immunity atlas in PD by profiling PBMCs from PD-Early, PD-Late patients and matched controls. By enlarging the blood sample size, we validated the roles of NK cells in numerous immune-related biological processes. We also detected the infiltration of NK cells into the cerebral motor cortex as the disease progressed, using human brain sections, and elucidated the communication between the periphery and CNS and its implications for PD. As a result, cell subpopulation atlases in PBMCs from PD patients and healthy controls along with differentially expressed genes in NK cells were identified by scRNA-seq analysis, representing 6 major immune cell subsets among which NK cells declined in the progression of PD. We further validated NK cell reduction in increasing samples and found that they participated in numerous immune-related biological processes and infiltration into the cerebral motor cortex as the disease proceeded, evidencingd the close communication between the peripheral immune response and CNS. Strikingly, XCL2 positively correlated with PD severity, with good predictive performance of PD and specific expression in subclusters C2 and C5 of NK cells. All these findings delineated the critical role of peripheral immune response mediated by NK cells in the pathogenesis of PD. NK cell-specific XCL2 could be used as a diagnostic marker for treating PD. The indispensable function of NK cells and NK cell-specific molecular biomarkers highlighted the implication of the peripheral immune response in PD progression. Trial registration: ChiCTR, ChiCTR1900023975. Registered 20 June 2019 - Retrospectively registered, https://www.chictr.org.cn/showproj.html?proj=31035 .
-
Genetic Impacts on Nigral Iron Deposition in Parkinson's Disease: A Preliminary Quantitative Susceptibility Mapping Study.
Jingjing Wu,Tao Guo,Cheng Zhou,Xueqin Bai,Xiaocao Liu,Luyan Gu,Min Xuan,Quanquan Gu,Peiyu Huang,Zhe Song,Baorong Zhang,Xiaojun Xu,Minming Zhang,Xiaojun Guan
DOI: https://doi.org/10.1111/cns.14135
2023-01-01
CNS Neuroscience & Therapeutics
Abstract:BACKGROUND:Dysfunction of iron metabolism, especially in substantia nigra (SN), is widely acknowledged in Parkinson's disease (PD), but the genetic influence on iron deposition remains largely unknown. Thus, in this study, we aimed to investigate potential genetic impacts on iron deposition in PD.METHODS:Seventy-four subjects, including 38 patients with PD and 36 age-matched normal controls, participated in this study. Imaging genetic association analysis was used to identify the specific influence of single nucleotide polymorphism (SNP) on iron-related quantitative traits (QT). Genetic effects on iron deposition at the disease level, SNP level, and their interactive effect were highlighted.RESULTS:Four strong SNP-QT associations were detected: rs602201-susceptibility of bilateral SN, rs198440-susceptibility of left SN, and rs7895403-susceptibility of left caudate head. Detailed analyses showed that: (1) significant iron deposition was exclusively found in bilateral SN in PD; (2) altered polymorphisms of the A allele/A- genotype of rs602201 and G allele/G- genotype of rs198440 and rs7895403 were more frequently observed in PD; (3) for rs602201, among all subjects, A- genotype carriers showed significantly increased iron content than TT genotype in bilateral SN; for rs198440 and rs7895403, G- carriers showed increased iron content than AA genotype in left SN and left caudate head, respectively; and (4) rs602201 exhibited significant SNP-by-disease interaction in bilateral SN.CONCLUSIONS:This study shows that rs602201 and rs198440 have a stimulative impact on nigral iron deposition in PD, which provides improved understanding of iron-related pathogenesis in PD, and specifically, that vulnerability to iron deposition in SN is genetic-based.
-
[Association of the Polymorphisms in NURR1 Gene with Parkinson's Disease].
Yan Wu,Rong Peng,Wenjun Chen,Jinhong Zhang,Tao Li,Yingcheng Wang,Yingru Gou,Guanggu Yuan
DOI: https://doi.org/10.3321/j.issn:1003-9406.2008.06.021
2008-01-01
Abstract:OBJECTIVE:To investigate the association between the polymorphisms of [c.-2922(C)2-3 and IVS6+ 18insG] in the NURR1 gene and Parkinson's disease (PD) in a Han population from Sichuan province.METHODS:PCR, allele-specific PCR (AS-PCR) and restriction fragment length polymorphism (RFLP) were used to determine the genotype of each subject.RESULTS:The two polymorphic sites in 241 PD patients and 236 controls with matched age, gender and ethnicity were analyzed. In the IVS6+ 18insG site, the difference of genotype frequencies of 3G/3G, 3G/2G and 2G/2G was not statistically significant. However, the 3G/2G genotype frequency was significantly higher in the PD with age of onset being < 50 years than that in controls (chi (2)= 6.537, P= 0.011; OR= 1.913, 95%CI: 1.159-3.158). No significant differences were found in allele and genotype frequencies of the c.-2922(C)2-3 site in the promoter region between the PD and controls (P= 0.766).CONCLUSION:This study suggested that the IVS6+ 18insG polymorphism may be associated with genetic susceptibility of PD with age of onset being < 50 years and the c.-2922(C)2-3 site in the promoter region may not be a risk factor for PD in authors' patient group.
-
Genetic Variants In The Rab7l1 And Slc41a1 Genes Of The Park16 Locus In Chinese Parkinson'S Disease Patients
Yaping Yan,Jun Tian,Xiaoyun Mo,Guohua Zhao,Xinzhen Yin,Jiali Pu,Baorong Zhang
DOI: https://doi.org/10.3109/00207454.2011.598983
2011-01-01
International Journal of Neuroscience
Abstract:We performed direct DNA sequencing of the RAB7L1 and SLC41A1 genes within the PARK16 locus in 205 Chinese Parkinson's disease (PD) patients. Three novel heterozygous variants were identified in SLC41A1: c.436A > G (causing p.Lys146Glu), c.1440A > G (causing p.Pro480Pro), and c.552 + 50G > A. These three variants were not present in any of the 210 genetically unrelated healthy controls of the same ethnic origin. No changes were identified in the RAB7L1 gene. Additionally, for the eight core PARK16 SNPs, no significant difference in allele or genotype frequencies was observed between PD patients and controls. Further analysis is required to determine the role of genes within the PARK16 locus in development of PD.
-
Association Analysis and Polygenic Risk Score Evaluation of 38 Gwas-Identified Loci in A Chinese Population with Parkinson'S Disease
Ran Zheng,Song Qiao,Ying Chen,Chongyao Jin,Yi Fang,Zhihao Lin,Naijia Xue,Yiqun Yan,Luyan Gu,Ting Gao,Jun Tian,Yaping Yan,Xinzhen Yin,Jiali Pu,Baorong Zhang
DOI: https://doi.org/10.1016/j.neulet.2021.136150
IF: 3.197
2021-01-01
Neuroscience Letters
Abstract:Objective: Recently, a meta-analysis of genome-wide association studies (GWASs) has identified 38 novel independent loci associated with risk of Parkinson's disease (PD) in European populations. We sought to investigate whether these genetic susceptibility variants could be replicated in the Chinese Han population. Methods: We genotyped 38 independent loci in 495 Chinese sporadic PD patients and 470 unrelated controls and performed allelic and genotypic association test using chi-square tests or Armitage test for trend. Polygenic risk score (PRS) models were built to evaluate the cumulative effects of the selected SNPs. Results: We found that the rs11610045 of FBRSL1 (p = 0.02, OR = 0.63, allele model), rs76116224 of KCNS3 (p < 0.01, OR = 0.09, allele model), and the rs2248244 of DYRK1A (p = 0.02, OR = 1.35, allele model) were significantly associated with PD. The PRS model of cumulative effects of the SNPs associated with PD in our study had the area under the curve (AUC) of 0.61. Conclusions: Our study revealed that rs11610045 of FBRSL1, rs76116224 of KCNS3 and rs2248244 of DYRK1A showed an impact on the risk of PD, and the GWAS-derived PRS models we built had predictive value for PD risk in the Chinese population. Further studies are needed to explore the pathogenesis of these potentially riskassociated variants.